| SpectraBase Spectrum ID |
DlzDxoaAvk8 |
| Name |
Stanozolol |
| CAS Registry Number |
10418-03-8 |
| Classification |
Pharmaceutical drug, anabolic androgenic |
| Comments |
Spectrum verified by crosschecking against external libraries (one reference spectrum with similarity >= 99% found); Spectrum verified by independent measurements in external laboratories |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| DEA Citation |
21 CFR §1308.13 (f) (81) |
| DEA Controlled Substance Name |
stanozolol |
| DEA Controlled Substance Type |
Salts, esters and ethers |
| DEA Controlled Substances Code Number |
4000 |
| DEA Schedule |
Schedule III |
| DEA Section |
Anabolic Steroids. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation containing any quantity of the following substances, including its salts, esters and ethers. |
| Exact Mass |
328.251463657 u |
| Formula |
C21H32N2O |
| InChI |
InChI=1S/C21H32N2O/c1-19-11-13-12-22-23-18(13)10-14(19)4-5-15-16(19)6-8-20(2)17(15)7-9-21(20,3)24/h12,14-17,24H,4-11H2,1-3H3,(H,22,23)/t14-,15+,16-,17-,19-,20-,21-/m0/s1 |
| InChIKey |
LKAJKIOFIWVMDJ-IYRCEVNGSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
328.500 g/mol |
| Nominal Mass |
328 u |
| Quality |
963 |
| Retention Index |
3082 |
| SMILES |
O[C@@]1([C@@]2([C@]([C@]3([C@@]([C@@]4([C@](CC=5C(C4)=CNN5)(CC3)[H])C)(CC2)[H])[H])(CC1)[H])C)C |
| SPLASH |
splash10-002e-9743000000-5edc417217815b4f834f |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Andro-stanazol
Stanazol
Stanazolol
17beta-Methyl-2'H-5alpha-androst-2-enol-[3,2-c]pyrazol-17-ol |
| Technique |
GC/MS |
| Wiley ID |
DD2024_018319 |
